Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection - a new frontier?

Critical Care

Volumn 16, Issue 3, 2012, Pages

  Afshari, Arash ^a,b   Schrenzel, Jacques ^a   Ieven, Margareta ^c   Harbarth, Stephan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER INFECTION; ASPERGILLOSIS; BACILLUS CEREUS INFECTION; BACTEREMIA; BACTEROIDES INFECTION; BLOOD CULTURE; BLOODSTREAM INFECTION; BURKHOLDERIA CEPACIA INFECTION; CAMPYLOBACTERIOSIS; CANDIDIASIS; CHEMOLUMINESCENCE; CLINICAL DECISION MAKING; CLOSTRIDIUM PERFRINGENS INFECTION; CRITICALLY ILL PATIENT; ELECTROSPRAY MASS SPECTROMETRY; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTION; FLUORESCENCE; FOOD AND DRUG ADMINISTRATION; GEL ELECTROPHORESIS; GOLD STANDARD; HAEMOPHILUS INFECTION; HOSPITAL INFORMATION SYSTEM; HUMAN; IN SITU HYBRIDIZATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE INFECTION; LISTERIOSIS; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; NEISSERIACEAE INFECTION; NONHUMAN; PATHOGENESIS; PNEUMOCOCCAL INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEUS INFECTION; PSEUDOMONAS INFECTION; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SERRATIA INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; YERSINIA INFECTION; BLOOD; GENETIC PROCEDURES; INTENSIVE CARE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POINT OF CARE SYSTEM; PROCEDURES;

BACTERIAL DNA;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; CRITICAL CARE; DNA, BACTERIAL; GENETIC TECHNIQUES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE SYSTEMS;

EID: 84861657004     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11202     Document Type: Review

References (106)

1. Melamed A, Sorvillo FJ. The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiplecause-of-death data. Crit Care 2009, 13:R28. 10.1186/cc7733, 2688146, 19250547.
2. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, Mayer K, Oppert M, Olthoff D, Quintel M, Ragaller M, Rossaint R, Stuber F, Weiler N, Welte T, Bogatsch H, Hartog C, Loeffler M, Reinhart K. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 2007, 33:606-618. 10.1007/s00134-006-0517-7, 17323051.
3. Harbarth S, Garbino J, Pugin J, Romand J, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003, 115:529-535. 10.1016/j.amjmed.2003.07.005, 14599631.
4. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D, . Cooperative Antimicrobial Therapy of Septic Shock Database Research Group Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009, 136:1237-1248. 10.1378/chest.09-0087, 19696123, Cooperative Antimicrobial Therapy of Septic Shock Database Research Group.
5. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N'Doye B, Pittet D, Richtmann R, Seto WH, van der Meer JW, Voss A. Society's failure to protect a precious resource: antibiotics. Lancet 2011, 378:369-371. 10.1016/S0140-6736(11)60401-7, 21477855.
6. Binder U, Lass-Flörl C. Epidemiology of invasive fungal infections in the mediterranean area. Mediterr J Hematol Infect Dis 2011, 3:e20110016. 3103242, 21625305.
7. Miceli MH, Lee SA. Emerging moulds: epidemiological trends and antifungal resistance. Mycoses 2011, 54:e666-678. 10.1111/j.1439-0507.2011.02032.x, 21672045.
8. Bassetti M, Ginocchio F, Giacobbe DR. New approaches for empiric therapy in Gram-positive sepsis. Minerva Anestesiol 2011, 77:821-827.
9. Spapen H, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011, 1:14. 10.1186/2110-5820-1-14, 3224475, 21906345.
10. Kane-Gill SL, Jacobi J, Rothschild JM. Adverse drug events in intensive care units: risk factors, impact, and the role of team care. Crit Care Med 2010, 38:S83-89.
11. Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003, 123:1615-1624.
12. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, Aldabó-Pallás T, Cayuela-Dominguez A, Marquez-Vacaro JA, Carbajal-Guerrero J, Garcia-Garmendia JL. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 2008, 61:436-441.
13. Juan-Torres A, Harbarth S. Prevention of primary bacteraemia. Int J Antimicrob Agents 2007, (Suppl 1):S80-87.
14. Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis 2009, 48:S238-S245. 10.1086/598188, 19374579.
15. Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev 2010, 23:235-251. 10.1128/CMR.00043-09, 2806664, 20065332.
16. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents 2007, 30:S7-S15.
17. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007, 7:645-657. 10.1016/S1473-3099(07)70235-9, 17897607.
18. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart 2003, 89:258-262. 10.1136/heart.89.3.258, 1767579, 12591823.
19. Lee A, Mirrett S, Reller LB, Weinstein MP. Detection of bloodstream infections in adults: how many blood cultures are needed?. J Clin Microbiol 2007, 45:3546-3548. 10.1128/JCM.01555-07, 2168497, 17881544.
20. Connell TG, Rele M, Cowley D, Buttery JP, Curtis N. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 2007, 119:891-896. 10.1542/peds.2006-0440, 17473088.
21. Yagupsky P, Nolte FS. Quantitative aspects of septicemia. Clin Microbiol Rev 1990, 3:269-279. 358159, 2200606.
22. Leggieri N, Rida A, François P, Schrenzel J. Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis 2010, 23:311-319.
23. Shah SS, Downes KJ, Elliott MR, Bell LM, McGowan KL, Metlay JP. How long does it take to ''rule out'' bacteremia in children with central venous catheters?. Pediatrics 2008, 121:135-141. 10.1542/peds.2007-1387, 18166567.
24. Peralta G, Rodriguez-Lera MJ, Garrido JC, Ansorena L, Roiz MP. Time to positivity in blood cultures of adults with Streptococcus pneumoniae bacteremia. BMC Infect Dis 2006, 6:79. 10.1186/1471-2334-6-79, 1475865, 16643662.
25. Okeke IN, Peeling RW, Goossens H, Auckenthaler R, Olmsted SS, de Lavison JF, Zimmer BL, Perkins MD, Nordqvist K. Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat 2011, 14:95-106. 10.1016/j.drup.2011.02.002, 21398170.
26. Wolk DM, Struelens MJ, Pancholi P, Davis T, Della-Latta P, Fuller D, Picton E, Dickenson R, Denis O, Johnson D, Chapin K. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J Clin Microbiol 2009, 47:823-826. 10.1128/JCM.01884-08, 2650929, 19144803.
27. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010, 51:1074-1080. 10.1086/656623, 20879856.
28. Parta M, Goebel M, Thomas J, Matloobi M, Stager C, Musher DM. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol 2010, 31:1043-1048. 10.1086/656248, 20731594.
29. Costa AM, Kay I, Palladino S. Rapid detection of mecA and nuc genes in staphylococci by real-time multiplex polymerase chain reaction. Diagn Microbiol Infect Dis 2005, 51:13-17. 10.1016/j.diagmicrobio.2004.08.014, 15629224.
30. Stamper PD, Cai M, Howard T, Speser S, Carroll KC. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J Clin Microbiol 2007, 45:2191-2196. 10.1128/JCM.00552-07, 1932973, 17522275.
31. Ho TH, Huang YC, Lin TY. Evaluation of the BD GeneOhm StaphSR assay for detection of Staphylococcus aureus in patients in intensive care units. J Microbiol Immunol Infect 2011, 44:310-315. 10.1016/j.jmii.2010.08.008, 21524966.
32. Gröbner S, Dion M, Plante M, Kempf VA. Evaluation of the BD GeneOhm StaphSR assay for detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from spiked positive blood culture bottles. J Clin Microbiol 2009, 47:1689-1694. 10.1128/JCM.02179-08, 2691102, 19369439.
33. Snyder JW, Munier GK, Heckman SA, Camp P, Overman TL. Failure of the BD GeneOhm StaphSR assay for direct detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates in positive blood cultures collected in the United States. J Clin Microbiol 2009, 47:3747-3748. 10.1128/JCM.01391-09, 2772621, 19794051.
34. Tissari P, Zumla A, Tarkka E, Mero S, Savolainen L, Vaara M, Aittakorpi A, Laakso S, Lindfors M, Piiparinen H, Mäki M, Carder C, Huggett J, Gant V. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet 2010, 375:224-230. 10.1016/S0140-6736(09)61569-5, 20004964.
35. Ritchie A, Castán P. Aplicación de nuevas técnicas de microsecuenciación dirigida a la detección de bacterias mediante pyrosecuenciación. LifeScienceLab 2010, 1:2-3.
36. Wellinghausen N, Wirths B, Essig A, Wassill L. Evaluation of the Hyplex BloodScreen multiplex PCR-enzyme-linked immunosorbent assay system for direct identification of gram-positive cocci and gram-negative bacilli from positive blood cultures. J Clin Microbiol 2004, 42:3147-3152. 10.1128/JCM.42.7.3147-3152.2004, 446249, 15243074.
37. Avlami A, Bekris S, Ganteris G, Kraniotaki E, Malamou-Lada E, Orfanidou M, Paniara O, Pantazatou A, Papagiannitsis CC, Platsouka E, Stefanou I, Tzelepi E, Vagiakou H, Miriagou V. Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system. J Microbiol Methods 2010, 83:185-187. 10.1016/j.mimet.2010.08.014, 20807554.
38. Zhang K, McClure JA, Elsayed S, Louie T, Conly JM. Novel multiplex PCR assay for simultaneous identification of community-associated methicillin resistant Staphylococcus aureus strains USA300 and USA400 and detection of mecA and Panton-Valentine leukocidin genes, with discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J Clin Microbiol 2008, 46:1118-1122. 10.1128/JCM.01309-07, 2268379, 18160447.
39. Tang YW, Kilic A, Yang Q, McAllister SK, Li H, Miller RS, McCormac M, Tracy KD, Stratton CW, Han J, Limbago B. StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures. J Clin Microbiol 2007, 45:1867-1873. 10.1128/JCM.02100-06, 1933095, 17446323.
40. Buhan BW, Mackey T, Cahak C, Couillar H, Marla S, Raich T, Sauer L, Jannetto PJ, Ledeboer NA. Evaluation of the microarray-based sample-to-result Verigene BC-GP assay for rapid detection of Gram-positive bacteria and resistance determinants directly from positive blood cultures. , http://m.core-apps.com/TriStar-ICAAC11/abstract/9bd9d4e89691ff5649b4f0f841e4c862
41. Forrest GN. PNA FISH: present and future impact on patient management. Expert Rev Mol Diagn 2007, 7:231-236. 10.1586/14737159.7.3.231, 17489730.
42. Peleg AY, Tilahun Y, Fiandaca MJ, D'Agata EM, Venkataraman L, Moellering RC, Eliopoulos GM. Utility of peptide nucleic acid fluorescence in situ hybridization for rapid detection of Acinetobacter spp. and Pseudomonas aeruginosa. J Clin Microbiol 2009, 47:830-832. 10.1128/JCM.01724-08, 2650942, 19116347.
43. Forrest Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008, 52:3558-3563. 10.1128/AAC.00283-08, 2565911, 18663022.
44. Ly T, Gulia J, Pyrgos V, Waga M, Shoham S. Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 2008, 4:637-640. 2500257, 18827860.
45. Holtzman C, Whitney D, Barlam T, Miller NS. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol 2011, 49:1581-1582. 10.1128/JCM.02461-10, 3122789, 21270213.
46. Shepard JR, Addison RM, Alexander BD, Della-Latta P, Gherna M, Haase G, Hall G, Johnson JK, Merz WG, Peltroche-Llacsahuanga H, Stender H, Venezia RA, Wilson D, Procop GW, Wu F, Fiandaca MJ. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008, 46:50-55. 10.1128/JCM.01385-07, 2224311, 17977998.
47. La Scola B. Intact cell MALDI-TOF mass spectrometry-based approaches for the diagnosis of bloodstream infections. Expert Rev Mol Diagn 2011, 11:287-298.
48. Kok J, Thomas LC, Olma T, Chen SC, Iredell JR. Identification of bacteria in blood culture broths using matrix-assisted laser desorption-ionization Sepsityper™ and time of flight mass spectrometry. PLoS One 2011, 6:e23285. 10.1371/journal.pone.0023285, 3156714, 21858058.
49. Seng P, Rolain JM, Fournier PE, La Scola B, Drancourt M, Raoult D. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol 2010, 5:1733-1754. 10.2217/fmb.10.127, 21133692.
50. Drancourt M. Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review. Clin Microbiol Infect 2010, 16:1620-1625. 10.1111/j.1469-0691.2010.03290.x, 20545958.
51. Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, Schrenzel J. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol 2010, 48:1169-1175. 10.1128/JCM.01881-09, 2849558, 20164271.
52. Sanchez-Jimenez MM, Cardona-Castro N. Validation of a PCR for diagnosis of typhoid fever and salmonellosis by amplification of the hilA gene in clinical samples from Colombian patients. J Med Microbiol 2004, 53:875-878. 10.1099/jmm.0.45630-0, 15314194.
53. Rebollo MJ, San Juan Garrido R, Folgueira D, Palenque E, Díaz-Pedroche C, Lumbreras C, Aguado JM. Blood and urine samples as useful sources for the direct detection of tuberculosis by polymerase chain reaction. Diagn Microbiol Infect Dis 2006, 56:141-146. 10.1016/j.diagmicrobio.2006.03.018, 16698218.
54. Peters RP, van Agtmael MA, Gierveld S, Danner SA, Groeneveld AB, Vandenbroucke-Grauls CM, Savelkoul PH. Quantitative detection of Staphylococcus aureus and Enterococcus faecalis DNA in blood to diagnose bacteremia in patients in the intensive care unit. J Clin Microbiol 2007, 45:3641-3646. 10.1128/JCM.01056-07, 2168476, 17881553.
55. Klingspor L, Loeffler J. Aspergillus PCR formidable challenges and progress. Med Mycol 2009, 47:S241-S247. 10.1080/13693780802616823, 19253138.
56. Mühl H, Kochem AJ, Disqué C, Sakka SG. Activity and DNA contamination of commercial polymerase chain reaction reagents for the universal 16S rDNA real-time polymerase chain reaction detection of bacterial pathogens in blood. Diagn Microbiol Infect Dis 2010, 66:41-49. 10.1016/j.diagmicrobio.2008.07.011, 18722072.
57. Wellinghausen N, Kochem AJ, Disqué C, Mühl H, Gebert S, Winter J, Matten J, Sakka SG. Diagnosis of bacteremia in whole-blood samples by use of a commercial universal 16S rRNA gene-based PCR and sequence analysis. J Clin Microbiol 2009, 47:2759-2765. 10.1128/JCM.00567-09, 2738079, 19571030.
58. Gebert S, Siegel D, Wellinghausen N. Rapid detection of pathogens in blood culture bottles by real-time PCR in conjunction with the pre-analytic tool MolYsis. J Infect 2008, 57:307-316. 10.1016/j.jinf.2008.07.013, 18760842.
59. Mencacci A, Leli C, Cardaccia A, Montagna P, Moretti A, Bietolini C, Meucci M, Perito S, Cenci E, Bistoni F. Comparison of conventional culture with SeptiFast real-time PCR for microbial pathogen detection in clinical specimens other than blood. J Med Microbiol 2011, 60:1774-1778. 10.1099/jmm.0.034280-0, 21835970.
60. Sancho-Tello S, Bravo D, Borrás R, Costa E, Muñoz-Cobo B, Navarro D. Performance of the LightCycler SeptiFast test Mgrade in detecting microbial pathogens in purulent fluids. J Clin Microbiol 2011, 49:2988-2991. 10.1128/JCM.00359-11, 3147784, 21715593.
61. Fernández AL, Varela E, Martínez L, Martínez A, Sierra J, González-Juanatey JR, Regueiro B. Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis. Rev Esp Cardiol 2010, 63:1205-1208.
62. Lehmann LE, Hunfeld KP, Emrich T, Haberhausen G, Wissing H, Hoeft A, Stüber F. A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples. Med Microbiol Immunol 2008, 197:313-324. 10.1007/s00430-007-0063-0, 18008085.
63. Wallet F, Loïez C, Herwegh S, Courcol RJ. Usefulness of real-time PCR for the diagnosis of sepsis in ICU-acquired infections. Infect Disord Drug Targets 2011, 11:348-353.
64. Bravo D, Blanquer J, Tormo M, Aguilar G, Borrás R, Solano C, Clari MA, Costa E, Muñoz-Cobo B, Argüeso M, Pineda JR, Navarro D. Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. Int J Infect Dis 2011, 15:e326-331. 10.1016/j.ijid.2011.01.003, 21353616.
65. Josefson P, Strålin K, Ohlin A, Ennefors T, Dragsten B, Andersson L, Fredlund H, Mölling P, Olcén P. Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infections. Eur J Clin Microbiol Infect Dis 2011, 30:1127-1134. 10.1007/s10096-011-1201-6, 21373774.
66. Lehmann LE, Hauser S, Malinka T, Klaschik S, Weber SU, Schewe JC, Stüber F, Book M. Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR. PLoS One 2011, 6:e17146. 10.1371/journal.pone.0017146, 3040229, 21359187.
67. Figueroa JR, Ortiz J, Morales I. Use of the LightCycler SeptiFast test for rapid etiologic diagnosis of nosocomial infection in gynecological sepsis. Gynecol Obstet Invest 2010, 70:215-216. 10.1159/000318868, 20639648.
68. Maubon D, Hamidfar-Roy R, Courby S, Vesin A, Maurin M, Pavese P, Ravanel N, Bulabois CE, Brion JP, Pelloux H, Timsit JF. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect 2010, 61:335-342. 10.1016/j.jinf.2010.07.004, 20637801.
69. Avolio M, Diamante P, Zamparo S, Modolo ML, Grosso S, Zigante P, Tosoni N, De Rosa R, Stano P, Camporese A. Molecular identification of bloodstream pathogens in patients presenting to the emergency department with suspected sepsis. Shock 2010, 34:27-30. 10.1097/SHK.0b013e3181e7e80c, 20523273.
70. Paolucci M, Capretti MG, Dal Monte P, Corvaglia L, Landini MP, Varani S, Pession A, Faldella G, Sambri V. Laboratory diagnosis of late-onset sepsis in newborns by multiplex real-time PCR. J Med Microbiol 2009, 58:533-534. 10.1099/jmm.0.003848-0, 19273654.
71. Lucignano B, Ranno S, Liesenfeld O, Pizzorno B, Putignani L, Bernaschi P, Menichella D. Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis. J Clin Microbiol 2011, 49:2252-2258. 10.1128/JCM.02460-10, 3122766, 21471340.
72. Tsalik EL, Jones D, Nicholson B, Waring L, Liesenfeld O, Park LP, Glickman SW, Caram LB, Langley RJ, van Velkinburgh JC, Cairns CB, Rivers EP, Otero RM, Kingsmore SF, Lalani T, Fowler VG, Woods CW. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol 2010, 48:26-33. 10.1128/JCM.01447-09, 2812289, 19846634.
73. Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, Sugimoto H, Shimazu T, Tasaki O, Matsushima A, Ikeda Y, Okamoto S, Aikawa N, Hori S, Obara H, Ishizaka A, Hasegawa N, Takeda J, Kamihira S, Sugahara K, Asari S, Murata M, Kobayashi Y, Ginba H, Sumiyama Y, Kitajima M. Evaluationof pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. Crit Care 2010, 14:R159. 10.1186/cc9234, 2945143, 20731880.
74. Sachse S, Straube E, Lehmann M, Bauer M, Russwurm S, Schmidt KH. Truncated human cytidylate-phosphate-deoxyguanylate-binding protein for improved nucleic acid amplification technique-based detection of bacterial species in human samples. J Clin Microbiol 2009, 47:1050-1057. 10.1128/JCM.02242-08, 2668332, 19193840.
75. Lehmann LE, Alvarez J, Hunfeld KP, Goglio A, Kost GJ, Louie RF, Raglio A, Regueiro BJ, Wissing H, Stüber F. Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis. Crit Care Med 2009, 37:3085-3090. 10.1097/CCM.0b013e3181b033d7, 19633541.
76. Kaleta EJ, Clark AE, Johnson DR, Gamage DC, Wysocki VH, Cherkaoui A, Schrenzel J, Wolk DM. Use of PCR coupled with electrospray ionization mass spectrometry for rapid identification of bacterial and yeast bloodstream pathogens from blood culture bottles. J Clin Microbiol 2011, 49:345-353. 10.1128/JCM.00936-10, 3020459, 21048006.
77. Ecker DJ, Sampath R, Massire C, Blyn LB, Hall TA, Eshoo MW, Hofstadler SA. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008, 6:553-558. 10.1038/nrmicro1918, 18521073.
78. Hall TA, Sampath R, Blyn LB, Ranken R, Ivy C, Melton R, Matthews H, White N, Li F, Harpin V, Ecker DJ, McDougal LK, Limbago B, Ross T, Wolk DM, Wysocki V, Carroll KC. Rapid molecular genotyping and clonal complex assignment of Staphylococcus aureus isolates by PCR coupled to electrospray ionization mass spectrometry. J Clin Microbiol 2009, 47:1733-1741. 10.1128/JCM.02175-08, 2691079, 19297593.
79. Baldwin CD, Howe GB, Sampath R, Blyn LB, Matthews H, Harpin V, Hall TA, Drader JJ, Hofstadler SA, Eshoo MW, Rudnick K, Studarus K, Moore D, Abbott S, Janda JM, Whitehouse CA. Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. Diagn Microbiol Infect Dis 2009, 63:403-408. 10.1016/j.diagmicrobio.2008.12.012, 19232863.
80. Ecker DJ, Sampath R, Li H, Massire C, Matthews HE, Toleno D, Hall TA, Blyn LB, Eshoo MW, Ranken R, Hofstadler SA, Tang YW. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev Mol Diagn 2010, 10:399-415. 10.1586/erm.10.24, 20465496.
81. Sampath R, Hall TA, Massire C, Li F, Blyn LB, Eshoo MW, Hofstadler SA, Ecker DJ. Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci 2007, 1102:109-120. 10.1196/annals.1408.008, 17470915.
82. Eshoo MW, Crowder CD, Li H, Matthews HE, Meng S, Sefers SE, Sampath R, Stratton CW, Blyn LB, Ecker DJ, Tang YW. Detection and identification of Ehrlichia species in blood using PCR and electrospray ionization mass spectrometry. J Clin Microbiol 2010, 48:472-478. 10.1128/JCM.01669-09, 2815638, 19955274.
83. Kaleta EJ, Clark AE, Cherkaoui A, Wysocki VH, Ingram EL, Schrenzel J, Wolk DM. Comparative analysis of PCR-electrospray ionization/mass spectrometry(MS) and MALDI-TOF/MS for the identification of bacteria and yeast from positive blood culture bottles. Clin Chem 2011, 57:1057-1067. 10.1373/clinchem.2011.161968, 21576270.
84. Seegene. , http://seegene.com
85. Bizzini A, Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect 2010, 16:1614-1619. 10.1111/j.1469-0691.2010.03311.x, 20636422.
86. Tomas I, Alvarez M, Limeres J, Potel C, Medina J, Diz P. Prevalence, duration and aetiology of bacteraemia following dental extractions. Oral Dis 2007, 13:56-62. 10.1111/j.1601-0825.2006.01247.x, 17241431.
87. Dark PM, Dean P, Warhurst G. Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care 2009, 13:217. 10.1186/cc7886, 2750130, 19664174.
88. Dierkes C, Ehrenstein B, Siebig S, Linde HJ, Reischl U, Salzberger B. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis 2009, 9:126. 10.1186/1471-2334-9-126, 2739209, 19671147.
89. Lehmann LE, Herpichboehm B, Kost GJ, Kollef MH, Stüber F. Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care 2010, 14:R186. 10.1186/cc9294, 3219292, 20950442.
90. Maaroufi Y, Ahariz N, Husson M, Crokaert F. Comparison of different methods of isolation of DNA of commonly encountered Candida species and its quantitation by using a real-time PCR-based assay. J Clin Microbiol 2004, 42:3159-3163. 10.1128/JCM.42.7.3159-3163.2004, 446303, 15243076.
91. Dineva MA, MahiLum-Tapay L, Lee H. Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource limited settings. Analyst 2007, 132:1193-1199. 10.1039/b705672a, 18318279.
92. Klouche M, Schröder U. Rapid methods for diagnosis of bloodstream infections. Clin Chem Lab Med 2008, 46:888-908.
93. Peters RP, Mohammadi T, Vandenbroucke-Grauls CM, Danner SA, van Agtmael MA, Savelkoul PH. Detection of bacterial DNA in blood samples from febrile patients: underestimated infection or emerging contamination?. FEMS Immunol Med Microbiol 2004, 42:249-253. 10.1016/j.femsim.2004.05.009, 15364111.
94. Kline KA, Fälker S, Dahlberg S, Normark S, Henriques-Normark B. Bacterial adhesins in host-microbe interactions. Cell Host Microbe 2009, 5:580-592.
95. Rubtsova MY, Ulyashova MM, Bachmann TT, Schmid RD, Egorov AM. Multiparametric determination of genes and their point mutations for identification of beta-lactamases. Biochemistry 2010, 75:1628-1649.
96. Rello J, Lisboa T, Lujan M, Gallego M, Kee C, Kay I, Lopez D, Waterer GW, . DNA-Neumococo Study Group Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009, 136:832-840. 10.1378/chest.09-0258, 19433527, DNA-Neumococo Study Group.
97. Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome?. Clin Infect Dis 2007, 44:87-93. 10.1086/510075, 17143822.
98. Horisberger T, Harbarth S, Nadal D, Baenziger O, Fischer JE. G-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model. Study protocol of a randomized controlled trial. Crit Care 2004, 8:R443-450. 10.1186/cc2971, 1065067, 15566590.
99. Cohen D, Billingsley M. Europeans are left to their own devices. BMJ 2011, 342:d2748. 10.1136/bmj.d2748, 21572130.
100. Wilmshurst P. The regulation of medical devices. BMJ 2011, 342:d2822. 10.1136/bmj.d2822, 21572131.
101. Fischer J, Harbarth S, Agthe A, Benn A, Ringer S, Goldmann D, Fanconi S. Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis 2004, 38:1383-1390. 10.1086/420741, 15156475.
102. Forrest GN, Mehta S, Weekes E, Lincalis DP, Johnson JK, Venezia RA. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother 2006, 58:154-158. 10.1093/jac/dkl146, 16636084.
103. Westh H, Lisby G, Breysse F, Böddinghaus B, Chomarat M, Gant V, Goglio A, Raglio A, Schuster H, Stuber F, Wissing H, Hoeft A. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect 2009, 15:544-551. 10.1111/j.1469-0691.2009.02736.x, 19392905.
104. Lindholm L, Sarkkinen H. Direct identification of gram-positive cocci from routine blood cultures by using AccuProbe tests. J Clin Microbiol 2004, 42:5609-5613. 10.1128/JCM.42.12.5609-5613.2004, 535217, 15583289.
105. Arbique JC, Poyart C, Trieu-Cuot P, Quesne G, Carvalho Mda G, Steigerwalt AG, Morey RE, Jackson D, Davidson RJ, Facklam RR. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin Microbiol 2004, 42:4686-4696. 10.1128/JCM.42.10.4686-4696.2004, 522306, 15472328.
106. Bogaerts P, de Mendonça R, Huang TD, Markine-Goriaynoff N, de Longueville F, Roisin S, Plüster W, Denis O, Glupczynski Y. Validation of a novel high multiplexing real-time PCR array for the identification and characterization of bacteria causative of ventilator-associated pneumonia. , http://m.core-apps.com/TriStar-ICAAC11/abstract/9bd9d4e89691ff5649b4f0f841e6c73a